The NNEF’s 2009 All Day Meeting and AGM took place on March 9th at Liverpool John Moores University. The morning session, the World Health Organization (WHO) and the National Institute for Health and Clinical Excellence (NICE) presented their major new reports on needle exchange, and the NNEF presented the findings of the recent Members Survey on aluminium foil distribution.

The National Needle Exchange Forum hosted a ‘Fringe Meeting’ at the National Conference on Injecting Drug Use (NCIDU) in London. We used the opportunity to launch a survey and consultation for NNEF members on the issue of foil provision in needle exchanges.

This meeting for NNEF members was held on Friday 4th April at Enterprise Park Conference Centre, Derby. The programme included a presentation from the National Treatment Agency, and discussions on interventions for crack cocaine users, steroid use, and the Mental Capacity Act. The 2008 NNEF Annual General Meeting was also held.

The 2007 NNEF meeting was held on Friday 6th July at the Birmingham Centre for Voluntary Action. Presentations on the day included ones from the National Treatment Agency feeding back the finding of the national NSP survey, and a presentation on water for injections.

This NNEF meeting was held on October 13th 2005 at the Victoria Park Plaza Hotel in London – the venue for the 2005 National Conference on Injecting Drug Use (which took place the following day). The agenda featured presentations from Monique Tomlinson and Neil Hunt (‘Feedback from the UKHRA Consultation on Harm Reduction in the UK’), Jonathan Edwards (‘NHS Logistics National Agreement for Needle Exchange Packs in England’), and Wendy Rayner (‘Needle Exchange Waste Disposal’), as well as a regional round-up and open forum.

NNEF meeting held at Friend’s Meeting House in London on 25th February 2005. Included a presentation on the Needle Exchange Survey Research by Dawn Gordon and Ross Coomber.

Meeting held at: Meeting Room J, Regents College London on 1st April 2004. Included presentations on Injecting Paraphernalia, the Quality of BD Insulin Needles and Mike Ashton’s Drug and Alcohol Findings.